Bond.az White LogoBond.az Black Logo

BofA Raises Nio Price Target to $6.80

BofA raises Nio price target to $6.80 on improved margin outlook. Get the latest analysis and stock insights at Bond.az.

Sophia Anderson
BySophia Anderson- Senior Editor
|
0

BofA Securities raised its price target on Nio Inc. (NYSE:NIO) to $6.80 from $6.70 while maintaining a Neutral rating. The stock trades at $5.64, implying roughly 20% upside.

Bond.az data indicates the company appears undervalued, with a Fair Value of $7.34. The firm adjusted estimates after Nio's first-quarter 2026 results.

BofA lifted 2026 and 2027 sales volume forecasts by 1% each and increased gross profit margin estimates by 1.4 percentage points for both years. According to Bond.az, 2 analysts have revised earnings upwards.

Nio's gross profit margin stood at 13.62% over the last twelve months. BofA raised its 2026 non-GAAP net profit estimate by 593% and its 2027 estimate by 23%.

Analyst Ming Hsun Lee reiterated a Neutral rating, citing strong model pipeline and OPEX partially offset by sector headwinds.

Nio recently reported its first quarterly net profit in Q4 2025, with net income of RMB 0.12 billion. Revenue hit RMB 34.7 billion, up 76% YoY.

HSBC upgraded Nio to Buy with a $6.80 target. Nio also unveiled the ONVO L80 SUV, with pre-orders open.

More News
2026-06-01 12:02
|
743

Legend Biotech Buy Rating Reiterated

H.C. Wainwright reiterated its Buy rating for Legend Biotech with a $50 target. Revenue up 56% over twelve months.

0
2026-06-01 12:01
|
475

Cogent Stock Price Target Raised to $55

Cogent Biosciences PEAK trial: combination therapy shows 45.6% response rate, 16.5 months PFS, FDA accepts NDA. H.C. Wainwright raises price target to $55.

0
2026-06-01 12:00
|
842

H.C. Wainwright Reaffirms Mineralys Buy

H.C. Wainwright reiterated a Buy rating on Mineralys Therapeutics with a $56 price target after positive trial data.

0
2026-06-01 10:33
|
714

Goldman Sachs Upgrades Marriott Vacations Stock

Goldman Sachs upgrades Marriott Vacations stock to Buy, price target $100. Execution potential drives earnings upside.

0
2026-06-01 10:32
|
730

Goldman Sachs Upgrades Travel + Leisure Stock to Buy

Goldman Sachs upgraded Travel + Leisure stock to Buy with a $85 price target. Learn about the company's financials, dividends, and market outlook.

0
2026-06-01 10:32
|
238

Canaccord Initiates Rare Earths Americas with Buy

Canaccord Genuity initiates Rare Earths Americas with a buy rating and $25 target. Stock at $21.85, offering 14% upside potential.

0
2026-06-01 10:30
|
651

BofA Raises Icon Stock Target to $125 on Bookings

BofA Securities raised Icon plc price target to $125, maintains Underperform. Improved booking trends and Q4 results drive revision.

0
2026-06-01 10:03
|
748

RBC Capital: Sprouts faces Kroger risk

RBC Capital keeps Sprouts rating but sees risks from Kroger price cuts. Analysis and outlook on Bond.az.

0
2026-06-01 09:02
|
551

CLSA Rates Chagee Hold on Margins

CLSA initiated Chagee Holdings with Hold rating and $10 target. Bond.az analysis reveals stock may be undervalued. Read more.

0
2026-06-01 08:31
|
594

Barclays Downgrades Sensata Stock on Valuation

Barclays downgrades Sensata stock to Equalweight on valuation concerns, but raises price target to $53. Stock surged 92% in past year.

0
2026-06-01 08:05
|
946

UBS Initiates Veritone Coverage with Neutral

UBS initiated coverage on Veritone with a Neutral rating and $2.50 price target. The AI company is better positioned for growth after transformation.

0
2026-06-01 08:02
|
892

JMP Securities Initiates Microsoft with Outperform on AI Strategy

JMP Securities initiates Microsoft with Market Outperform rating and $550 target on AI strategy. Revenue growth expected to reach 17% in FY2026.

0
...
BofA Raises Nio Price Target to $6.80 | Bond.az